• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症导致 COVID-19 恶化:皮肤炎症呢?

Inflammation Causes Exacerbation of COVID-19: How about Skin Inflammation?

机构信息

Department of Dermatology, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke 329-0498, Tochigi, Japan.

出版信息

Int J Mol Sci. 2022 Oct 14;23(20):12260. doi: 10.3390/ijms232012260.

DOI:10.3390/ijms232012260
PMID:36293117
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9603600/
Abstract

COVID-19 is a recently emerged viral infection worldwide. SARS-CoV-2, the causative virus, is believed to have emerged from bat coronaviruses, probably through host conversion. The bat coronavirus which has the highest gene homology to SARS-CoV-2 specifically infects deep forest bats in China whose habitat extends through the Middle East to Southern Europe. Host conversion might have occurred due to the deforestation by humans exposing wild bats to the environment they had never encountered before. SARS-CoV-2 infects cells through two mechanisms: through its receptor ACE2 with the help of enzyme TMPRSS and through membrane fusion with the help of elastases in the inflammatory condition. Obesity, hypertension, diabetes mellitus, and pulmonary diseases cause poor prognosis of COVID-19. Aging is another factor promoting poor prognosis. These diseases and aging cause low-level and persistent inflammation in humans, which can promote poor prognosis of COVID-19. Psoriasis and atopic dermatitis are the major inflammatory skin diseases. These inflammatory skin conditions, however, do not seem to cause poor prognosis for COVID-19 based on the epidemiological data accumulated so far. These mechanisms need to be elucidated.

摘要

新型冠状病毒肺炎(COVID-19)是一种新出现的全球病毒性传染病。目前认为,引发 COVID-19 的病原体 SARS-CoV-2 可能来源于蝙蝠冠状病毒,通过宿主转换而出现。与 SARS-CoV-2 基因同源性最高的蝙蝠冠状病毒,主要感染中国的深山蝙蝠,其栖息地从中东延伸到南欧。人类砍伐森林,使野生蝙蝠暴露于前所未有的环境中,可能导致了宿主转换。SARS-CoV-2 通过两种机制感染细胞:一种是通过其受体 ACE2 并在酶 TMPRSS 的帮助下,另一种是在炎症条件下通过弹性蛋白酶帮助膜融合。肥胖、高血压、糖尿病和肺部疾病导致 COVID-19 的预后不良。衰老也是导致预后不良的另一个因素。这些疾病和衰老导致人类发生低度和持续的炎症,从而可能导致 COVID-19 的预后不良。银屑病和特应性皮炎是主要的炎症性皮肤病。然而,根据迄今为止积累的流行病学数据,这些炎症性皮肤疾病似乎不会导致 COVID-19 的预后不良。这些机制需要进一步阐明。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b155/9603600/ce7446aadaaa/ijms-23-12260-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b155/9603600/64dee2c67b77/ijms-23-12260-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b155/9603600/346717851379/ijms-23-12260-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b155/9603600/edb328f4717f/ijms-23-12260-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b155/9603600/04a3d68af779/ijms-23-12260-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b155/9603600/ce7446aadaaa/ijms-23-12260-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b155/9603600/64dee2c67b77/ijms-23-12260-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b155/9603600/346717851379/ijms-23-12260-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b155/9603600/edb328f4717f/ijms-23-12260-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b155/9603600/04a3d68af779/ijms-23-12260-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b155/9603600/ce7446aadaaa/ijms-23-12260-g005.jpg

相似文献

1
Inflammation Causes Exacerbation of COVID-19: How about Skin Inflammation?炎症导致 COVID-19 恶化:皮肤炎症呢?
Int J Mol Sci. 2022 Oct 14;23(20):12260. doi: 10.3390/ijms232012260.
2
Regulatory T cell-like response to SARS-CoV-2 in Jamaican fruit bats (Artibeus jamaicensis) transduced with human ACE2.转导人 ACE2 的牙买加果蝠(Artibeus jamaicensis)对 SARS-CoV-2 的调节性 T 细胞样反应。
PLoS Pathog. 2023 Oct 19;19(10):e1011728. doi: 10.1371/journal.ppat.1011728. eCollection 2023 Oct.
3
Molecular evolution and phylogenetic analysis of SARS-CoV-2 and hosts ACE2 protein suggest Malayan pangolin as intermediary host.SARS-CoV-2 与宿主 ACE2 蛋白的分子进化和系统发育分析提示马来穿山甲可能为中间宿主。
Braz J Microbiol. 2020 Dec;51(4):1593-1599. doi: 10.1007/s42770-020-00321-1. Epub 2020 Jun 26.
4
Cross-Neutralization of SARS-CoV-2-Specific Antibodies in Convalescent and Immunized Human Sera against the Bat and Pangolin Coronaviruses.康复期和免疫接种后的人血清中针对蝙蝠和穿山甲冠状病毒的SARS-CoV-2特异性抗体的交叉中和作用。
Viruses. 2022 Aug 16;14(8):1793. doi: 10.3390/v14081793.
5
Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2.源自马蹄蝠 ACE2 直系同源物的突变增强了 ACE2-Fc 对 SARS-CoV-2 的中和作用。
PLoS Pathog. 2021 Apr 9;17(4):e1009501. doi: 10.1371/journal.ppat.1009501. eCollection 2021 Apr.
6
Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines.人冠状病毒 EMC 并不需要 SARS 冠状病毒受体,并且在哺乳动物细胞系中保持广泛的复制能力。
mBio. 2012 Dec 11;3(6):e00515-12. doi: 10.1128/mBio.00515-12.
7
[Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).].[新冠疫情的源头:冠状病毒(β冠状病毒:冠状病毒科)、严重急性呼吸综合征冠状病毒(SARS-CoV)、严重急性呼吸综合征冠状病毒2(SARS-CoV-2,Sarbecovirus亚属)和中东呼吸综合征冠状病毒(MERS-CoV,Merbecovirus亚属)的生态学与遗传学。]
Vopr Virusol. 2020;65(2):62-70. doi: 10.36233/0507-4088-2020-65-2-62-70.
8
Distinct evolutionary trajectories of SARS-CoV-2-interacting proteins in bats and primates identify important host determinants of COVID-19.SARS-CoV-2 与蝙蝠和灵长类动物相互作用的蛋白质具有不同的进化轨迹,这表明 COVID-19 的发生与宿主有重要关系。
Proc Natl Acad Sci U S A. 2022 Aug 30;119(35):e2206610119. doi: 10.1073/pnas.2206610119. Epub 2022 Aug 10.
9
Predicting mammalian species at risk of being infected by SARS-CoV-2 from an ACE2 perspective.从 ACE2 角度预测易感染 SARS-CoV-2 的哺乳动物物种。
Sci Rep. 2021 Jan 18;11(1):1702. doi: 10.1038/s41598-020-80573-x.
10
Mechanisms of COVID-19 pathogenesis in diabetes.COVID-19 发病机制在糖尿病中的研究进展。
Am J Physiol Heart Circ Physiol. 2022 Sep 1;323(3):H403-H420. doi: 10.1152/ajpheart.00204.2022. Epub 2022 Jul 1.

引用本文的文献

1
Editorial: Special Issue, "Molecular Advances in Skin Diseases 2.0".社论:特刊,“皮肤病学的分子进展 2.0”。
Int J Mol Sci. 2024 May 29;25(11):5928. doi: 10.3390/ijms25115928.
2
Impact of Different Traditional Chinese Medicine Constitutions on the Clinical Outcomes of COVID-19 Patients Infected with SARS-CoV-2 Omicron Variant: A Retrospective Observational Study.不同中医体质对感染新型冠状病毒奥密克戎变异株的新冠肺炎患者临床结局的影响:一项回顾性观察研究
Infect Drug Resist. 2023 Sep 25;16:6333-6344. doi: 10.2147/IDR.S424176. eCollection 2023.

本文引用的文献

1
Jakinibs of All Trades: Inhibiting Cytokine Signaling in Immune-Mediated Pathologies.全能的贾基尼布类药物:在免疫介导的疾病中抑制细胞因子信号传导
Pharmaceuticals (Basel). 2021 Dec 30;15(1):48. doi: 10.3390/ph15010048.
2
Impact of the COVID-19 pandemic on adults with moderate-to-severe atopic dermatitis in the Dutch general population.新冠疫情对荷兰普通人群中患有中度至重度特应性皮炎的成年人的影响。
JAAD Int. 2022 Mar;6:86-93. doi: 10.1016/j.jdin.2021.12.006. Epub 2021 Dec 28.
3
Association between atopic dermatitis and COVID-19 infection: A case-control study in the All of Us research program.
特应性皮炎与新型冠状病毒肺炎感染之间的关联:“我们所有人”研究项目中的一项病例对照研究
JAAD Int. 2022 Mar;6:77-81. doi: 10.1016/j.jdin.2021.12.007. Epub 2021 Dec 28.
4
A Literature Review of Real-World Effectiveness and Safety of Dupilumab for Atopic Dermatitis.度普利尤单抗治疗特应性皮炎的真实世界有效性和安全性文献综述。
JID Innov. 2021 Jul 30;1(3):100042. doi: 10.1016/j.xjidi.2021.100042. eCollection 2021 Sep.
5
The effect of allergy and asthma as a comorbidity on the susceptibility and outcomes of COVID-19.过敏和哮喘作为合并症对 COVID-19 的易感性和结局的影响。
Int Immunol. 2022 Mar 25;34(4):177-188. doi: 10.1093/intimm/dxab107.
6
COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab.度普利尤单抗治疗中重度特应性皮炎患者的 COVID-19 症状减轻。
J Allergy Clin Immunol Pract. 2022 Jan;10(1):134-142. doi: 10.1016/j.jaip.2021.10.050. Epub 2021 Nov 1.
7
Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19.肿瘤坏死因子抑制剂与 COVID-19 合并免疫介导的炎症性疾病患者住院或死亡风险的相关性。
JAMA Netw Open. 2021 Oct 1;4(10):e2129639. doi: 10.1001/jamanetworkopen.2021.29639.
8
Incidence and prognosis of COVID-19 in patients with psoriasis on apremilast: a multicentre retrospective cohort study.使用阿普斯特治疗的银屑病患者中新冠病毒疾病的发病率和预后:一项多中心回顾性队列研究
J Eur Acad Dermatol Venereol. 2022 Feb;36(2):e94-e95. doi: 10.1111/jdv.17749. Epub 2021 Oct 28.
9
Risk of COVID-19 and its complications in patients with atopic dermatitis undergoing dupilumab treatment-a population-based cohort study.患有特应性皮炎并接受度普利尤单抗治疗的患者罹患 COVID-19 及其并发症的风险:一项基于人群的队列研究。
Immunol Res. 2022 Feb;70(1):106-113. doi: 10.1007/s12026-021-09234-z. Epub 2021 Oct 13.
10
The risk of COVID-19 infection in patients with atopic dermatitis: A retrospective cohort study.特应性皮炎患者感染新型冠状病毒肺炎的风险:一项回顾性队列研究。
J Am Acad Dermatol. 2022 Jan;86(1):243-245. doi: 10.1016/j.jaad.2021.09.061. Epub 2021 Oct 6.